Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells

Oncogene

Volumn 24, Issue 55, 2005, Pages 8128-8143

  Syed, Viqar ^a   Zhang, Xiang ^a   Lau, Kin Mang ^a,b   Cheng, Robert ^a   Mukherjee, Kasturi ^a   Ho, Shuk Mei ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

5.1 RNA binding protein S1; Erythrocyte adducin subunit clone; Nuclear protein SkiP; Plexin A3; Rap 2; Sex gene

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN; PLEXIN; PLEXIN A3; PROTEIN; PROTEIN RAP 2; PROTEIN SKIP; RNA BINDING PROTEIN; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL IMMORTALIZATION; CELL INVASION; CELL LINE; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; ERYTHROCYTE; FEMALE; FUNCTIONAL ASSESSMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HORMONE ACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; UPREGULATION;

CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; EPITHELIAL CELLS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 6; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; OVARY; TRANSCRIPTION, GENETIC;

OXALIS TUBEROSA;

EID: 28744439266     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208959     Document Type: Article

References (88)

1. AACR (2005). Statistics.
2. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG and Lopez AM. (2003). JAMA, 290, 1739-1748.
3. Badolato J, Gardiner E, Morrison N and Eisman J. (1995). Gene, 166, 323-327.
4. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME and Nicosia SV. (2000). In vitro Cell Dev. Biol. Anim., 36, 657-666.
5. Bakken K, Alsaker E, Eggen AE and Lund E. (2004). Int. J. Cancer, 112, 130-134.
6. Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P and Lazennec G. (2004). Cancer Res., 64, 5861-5869.
7. Bast Jr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB and Knapp RC. (1981). J. Clin. Invest, 68, 1331-1337.
8. Baudino TA, Kraichely DM, Jefcoat Jr SC, Winchester SK, Partridge NC and MacDonald PN. (1998). J. Biol. Chem., 273, 16434-16441.
9. Bennett V and Baines AJ. (2001). Physiol. Rev., 81, 1353-1392.
10. Birkenmeier CS and Barker JE. (2004). J. Pathol., 204, 450-459.
11. Bowen SL, Bloor BK, Leigh IM and Waseem A. (2003). J. Pathol., 201, 119-126.
12. Callow ME, Callow JA, Ista LK, Coleman SE, Nolasco AC and Lopez GP. (2000). Appl. Environ. Microbiol., 66, 3249-3254.
13. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ. (1998). Oncogene, 17, 1395-1413.
14. Caron E, Self AJ and Hall A. (2000). Curr. Biol., 10, 974-978.
15. Chadwick CC, Chippari S, Matelan E, Borges-Marcucci L, Eckert AM, Keith Jr JC, Albert LM, Leathurby Y, Harris HA, Bhat RA, Ashwell M, Trybulski E, Winneker RC, Adelman SJ, Steffan RJ and Harnish DC. (2005). Proc. Natl. Acad. Sci. USA, 102, 2543-2548.
16. Cheng HJ, Bagri A, Yaron A, Stein E, Pleasure SJ and Tessier-Lavigne M. (2001). Neuron, 32, 249-263.
17. Dahl R, Wani B and Hayman MJ. (1998). Oncogene, 16, 1579-1586.
18. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA. (2003). Genome Biol., 4, 3.
19. DeNardo DG, Kim HT, Hilsenbeck S, Cuba V, Tsimelzon A and Brown PH. (2005). Mol. Endocrinol., 19, 362-378.
20. Faustino NA and Cooper TA. (2003). Genes Dev., 17, 419-437.
21. Folk P, Puta F, Krpejsova L, Blahuskova A, Markos A, Rabino M and Dottin RP. (1996). Gene, 181, 229-231.
22. Fowler L, Everitt J, Stevens JL and Jaken S. (1998). Cell Growth Differ., 9, 405-413.
23. Galtier-Dereure F, Capony F, Maudelonde T and Rochefort H. (1992). J. Clin. Endocrinol Metab., 75, 1497-1502.
24. Garg PP, Kerlikowske K, Subak L and Grady D. (1998). Obstet. Gynecol., 92, 472-479.
25. Ghisletti S, Meda C, Maggi A and Vegeto E. (2005). Mol. Cell. Biol., 25, 2957-2968.
26. Gorringe KL, Chin SF, Pharoah P, Staines JM, Oliveira C, Edwards PA and Caldas C. (2005). Carcinogenesis, 26, 923-930.
27. Hall JM and Korach KS. (2003). Mol. Endocrinol., 17, 792-803.
28. Heinonen PK, Tuimala R, Pyykko K and Pystynen P. (1982). Br. J. Obstet. Gynaecol., 89, 84-86.
29. Ho SM. (2003). Reprod. Biol. Endocrinol., 1, 73-80.
30. Ho SM, Lau KM, Mok SC and Syed V. (2003). Oncogene, 22, 4243-4256.
31. Hough CD, Cho KR, Zonderman AB, Schwartz DR and Morin PJ. (2001). Cancer Res., 61, 3869-3876.
32. Janoueix-Lerosey I, Polakis P, Tavitian A and de Gunzburg J. (1992). Biochem. Biophys. Res. Commun., 189, 455-464.
33. Jimenez B, Pizon V, Lerosey I, Beranger F, Tavitian A and de Gunzburg J. (1991). Int. J. Cancer, 49, 471-479.
34. Katabuchi H and Okamura H. (2003). Med. Electron Microsc., 36, 74-86.
35. Katagiri K, Hattori M, Minato N, Irie S, Takatsu K and Kinashi T. (2000). Mol. Cell. Biol., 20, 1956-1969.
36. Kim K, Barhoumi R, Burghardt R and Safe S. (2005). Mol. Endocrinol., 9, 843-854.
37. Kim VN, Kataoka N and Dreyfuss G. (2001). Science, 293, 1832-1836.
38. Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR and Berchuck A. (2004). J. Soc. Gynecol. Invest., 11, 51-59.
39. Langdon SP, Crew AJ, Ritchie AA, Muir M, Wakeling A, Smyth JF and Miller WR. (1994). Eur. J. Cancer, 30A, 682-686.
40. Langdon SP, Hawkes MM, Lawrie SS, Hawkins RA, Tesdale AL, Crew AJ, Miller WR and Smyth JF. (1990). Br. J. Cancer, 62, 213-216.
41. Langdon SP, Ritchie A, Young K, Crew AJ, Sweeting V, Bramley T, Hillier S, Hawkins RA, Tesdale AL and Smyth JF. (1993). Int. J. Cancer, 55, 459-464.
42. Lassus H, Leminen A, Lundin J, Lehtovirta P and Butzow R. (2003). Gynecol. Oncol., 91, 504-512.
43. Lau KM, Mok SC and Ho SM. (1999). Proc. Natl. Acad. Sci. USA, 96, 5722-5727.
44. Lau KM, Tam NN, Thompson C, Cheng RY, Leung YK and Ho SM. (2003). Lab. Invest., 83, 743-757.
45. Lee BC, Cha K, Avraham S and Avraham HK. (2004). Int. J. Oncol., 24, 847-851.
46. Leong GM, Subramaniam N, Figueroa J, Flanagan JL, Hayman MJ, Eisman JA and Kouzmenko AP. (2001). J. Biol. Chem., 276, 18243-18248.
47. Leong GM, Subramaniam N, Issa LL, Barry JB, Kino T, Driggers PH, Hayman MJ, Eisman JA and Gardiner EM. (2004). Biochem. Biophys. Res. Commun., 315, 1070-1076.
48. Lerosey I, Chardin P, de Gunzburg J and Tavitian A. (1991). J. Biol. Chem., 266, 4315-4321.
49. Lykke-Andersen J, Shu MD and Steitz JA. (2001). Science, 293, 1836-1839.
50. Maestrini E, Tamagnone L, Longati P, Cremona O, Gulisano M, Bione S, Tamanini F, Neel BG, Toniolo D and Comoglio PM. (1996). Proc. Natl. Acad. Sci. USA, 93, 674-678.
51. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, Wei JS, Giese A and Berens ME. (2001). J. Neurooncol., 53, 161-176.
52. Matsuoka Y, Li X and Bennett V. (2000). Cell Mol. Life Sci., 57, 884-895.
53. Mayeda A, Badolato J, Kobayashi R, Zhang MQ, Gardiner EM and Krainer AR. (1999). EMBO J., 18, 4560-4570.
54. McLeod SJ, Shum AJ, Lee RL, Takei F and Gold MR. (2004). J. Biol. Chem., 279, 12009-12019.
55. Nagata K, Itoh H, Katada T, Takenaka K, Ui M, Kaziro Y and Nozawa Y. (1989). J. Biol. Chem., 264, 17000-17005.
56. Nash JD, Ozols RF, Smyth JF and Hamilton TC. (1989). Obstet. Gynecol., 73, 1009-1016.
57. Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y and Kessler O. (2005). Front. Biosci., 10, 751-760.
58. Okamura H, Katabuchi H and Ohba T. (2003). Mol. Cell. Endocrinol., 202, 37-45.
59. Pavao M, Huang YH, Hafer LJ, Moreland RB and Traish AM. (2001). BMC Cancer, 1, 15.
60. Prathapam T, Kuhne C and Banks L. (2002). Nucleic Acids Res., 30, 5261-5268.
61. Quandt K, Frech K, Karas H, Wingender E and Werner T. (1995). Nucleic Acids Res., 23, 4878-4884.
62. Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, van Kooyk Y, Salmon M, Buckley CD and Bos JL. (2000). J. Cell Biol., 148, 1151-1158.
63. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E and Persson IR. (2002). J. Natl. Cancer Inst., 94, 497-504.
64. Riman T, Nilsson S and Persson IR. (2004). Acta Obstet. Gynecol. Scand., 83, 783-795.
65. Roche J and Drabkin HA. (2001). Clin. Lung Cancer, 3, 145-150.
66. Runge HM, Neumann HA, Bauknecht T and Pfleiderer A. (1986a). Eur. J. Cancer Clin. Oncol., 22, 691-696.
67. Runge HM, Teufel G, Neulen J, Geyer H and Pfleiderer A. (1986b). Cancer Chemother. Pharmacol., 16, 58-63.
68. Sakamoto M, Kondo A, Kawasaki K, Goto T, Sakamoto H, Miyake K, Koyamatsu Y, Akiya T, Iwabuchi H, Muroya T, Ochiai K, Tanaka T, Kikuchi Y and Tenjin Y. (2001). Hum. Cell, 14, 305-315.
69. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Gokden M, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy Jr J and Pecorelli S. (2004). Br. J. Cancer, 90, 1814-1824.
70. Simpson BJ, Langdon SP, Rabiasz GJ, Macleod KG, Hirst GL, Bartlett JM, Crew AJ, Hawkins RA, Macineira-Perez PP, Smyth JF and Miller WR. (1998). J. Steroid Biochem. Mol. Biol., 64, 137-145.
71. Sit AS, Modugno F, Weissfeld JL, Berga SL and Ness RB. (2002). Gynecol. Oncol., 86, 118-123.
72. Song J, Fadiel A, Edusa V, Chen Z, So J, Sakamoto H, Fishman DA and Naftolin F. (2005). Cancer Lett., 220, 57-65.
73. Stopper H, Schmitt E, Gregor C, Mueller SO and Fischer WH. (2003). Mutagenesis, 18, 243-247.
74. Sugimura M, Sagae S, Ishioka S, Nishioka Y, Tsukada K and Kudo R. (2004). Oncology, 66, 53-61.
75. Syed V and Ho SM. (2003). Oncogene, 22, 6883-6890.
76. Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, Tsuruo T and Ho SM. (2005). Oncogene, 24, 1774-1787.
77. Syed V, Ulinski G, Mok SC and Ho SM. (2002). J. Natl. Cancer Inst., 94, 617-629.
78. Syed V, Ulinski G, Mok SC, Yiu GK and Ho SM. (2001). Cancer Res., 61, 6768-6776.
79. Tamagnone L and Comoglio PM. (2000). Trends Cell Biol., 10, 377-383.
80. Taube M, Hockenstrom T, Isaksson M, Lindgren PR and Backstrom T. (2002). Int. J. Oncol., 20, 589-594.
81. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC and Berkowitz RS. (1995). Exp. Cell Res., 218, 499-507.
82. Tse C, Xiang RH, Bracht T and Naylor SL. (2002). Cancer Res., 62, 542-546.
83. Tsukamoto N, Hattori M, Yang H, Bos JL and Minato N. (1999). J. Biol. Chem., 274, 18463-18469.
84. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA and Hampton GM. (2001). Proc. Natl. Acad. Sci. USA, 98, 1176-1181.
85. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C and Naylor SL. (2002). Cancer Res., 62, 2637-2643.
86. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J and Speed TP. (2002). Nucleic Acids Res., 30, e15.
87. Zhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W and MacDonald PN. (2001). J. Biol. Chem., 276, 40614-40620.
88. Zhou S, Fujimuro M, Hsieh JJ, Chen L, Miyamoto A, Weinmaster G and Hayward SD. (2000). Mol. Cell. Biol., 20, 2400-2410.